FDA links ByHeart infant botulism outbreak to organic powdered milk

U.S. health officials and the Food and Drug Administration reported on Jan. 23 that testing had found the bacterium that causes botulism in unopened cans of ByHeart infant formula and in samples of organic whole milk powder used by the company. The discovery links the source of a recent infant botulism outbreak to a powdered ingredient rather than to handling after purchase, intensifying scrutiny of manufacturing and supply chain practices in baby food.

The identification of Clostridium botulinum in unopened product is particularly significant because powdered infant formula is not sterile by international and U.S. standards. Unlike ready-to-feed liquid formulas, powdered formula can contain spores from heat-resistant bacteria that survive processing. When environmental or ingredient contamination allows those spores to germinate and produce toxin, infants, whose immune systems and gut microbiomes are still developing, are at special risk of serious illness, including muscle weakness and respiratory failure.

Public health investigators have for weeks been tracing cases of infant botulism to the ByHeart product line. The FDA’s confirmation that the same organism was present in unopened cans and in the organic whole milk powder used in manufacturing supports a hypothesis long considered by epidemiologists: that the contamination originated upstream in the ingredient supply chain. That finding shifts attention to how powdered dairy ingredients are produced, stored and tested, and to the controls that manufacturers use to prevent spore-forming organisms from entering finished products.

Powdered whole milk is widely used in formula formulations for its nutrient profile, but its production typically involves spray-drying, which reduces but does not eliminate heat-resistant spores. The food safety challenge is compounded when suppliers, co-packers or ingredient processors lack uniform verification protocols or when traceability is limited across international supply chains. Public health officials will want to know whether the implicated powder carried spores at the time of delivery, whether contamination occurred during storage or handling at the plant, and whether environmental reservoirs in the facility contributed.

For parents and caregivers, the finding underscores the vulnerability of infants to foodborne pathogens and highlights the practical differences between formula types. Clinicians typically advise heightened vigilance for feeding difficulties, decreased movement, constipation and breathing problems, signs that warrant immediate medical attention. Health systems and pediatricians will need clear guidance from regulators about product testing, recall status and alternatives for infants who require formula.

Regulators face a dual imperative: to protect the immediate cohort of affected infants and to strengthen long-term safeguards for an industry that feeds millions of children. That will involve not only more intensive inspection and testing of finished products, but also a review of standards for critical ingredients, supplier audits, and advances in process validation that can better detect or inactivate spores before they reach vulnerable consumers.

The FDA and public health agencies have signaled that further investigation is underway to map the contamination pathway and to recommend actions to prevent recurrence. For now, the identification of the bacterium in unopened cans and in the organic powdered milk represents a rare and sobering confirmation that ingredients can be the origin of life-threatening contamination in infant food.